A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

Managing director & CEO Siddharth Mittal says is de-risking supply chain as Trump tariffs loom. 'We’re scenario-mapping but there’s a limit to how much we can do,' he tells Moneycontrol ...

Motilal Oswal is bullish on Gland Pharma has recommended buy rating on the stock with a target price of Rs 2340 in its ...

In the U.S. where adoption is highest, fewer than 1 in 10 adults are on a GLP-1 drug, despite nearly three-quarters being overweight or obese. Globally access is even more limited, held back by high ...

A trial of 3,127 patients who took a daily pill for 72 weeks saw an average weight loss per person of 12.3kg. While injectable obesity drugs are peptides designed to replicate the appetite-controlling ...